Partex.AI Technology leverages artificial intelligence to aid drug discovery and development for pharmaceutical companies, biotechnology firms, and contract research organizations. Headquartered in Eschborn, Germany, with offices in Pune, India, and the USA, it employs AI, machine learning, and blockchain technologies.
Founded in 2011, Partex.AI Technology offers services such as AI-powered drug discovery, therapeutic asset development, and real-world data integration. It operates on a B2B, SaaS, and platform business model, generating revenue through subscription fees, service fees, and licensing. The company focuses on biomedical data analysis, clinical trial optimization, and regulatory compliance to streamline the drug development process.